GLRA
ICPT
Gerald L. Ray & Associates’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-14,550
| Closed | -$1.76M | – | 335 |
|
|
2017
Q2 | $1.76M | Hold |
14,550
| – | – | 0.23% | 101 |
|
|
2017
Q1 | $1.65M | Buy |
14,550
+2,300
| +19% | +$260K | 0.23% | 101 |
|
|
2016
Q4 | $1.33M | Buy |
12,250
+7,210
| +143% | +$783K | 0.19% | 113 |
|
|
2016
Q3 | $830K | Buy |
5,040
+1,410
| +39% | +$232K | 0.12% | 150 |
|
|
2016
Q2 | $518K | Buy |
+3,630
| New | +$518K | 0.08% | 196 |
|